Tag Archives: SL

SP Fire Emerald Health Leadership Team

Supreme Announces Listing of Common Shares on the TSX.V under the symbol “FIRE”

Supreme Announces Listing of Common Shares on the TSX.V under the symbol “FIRE”

TORONTO, Ontario, June 1, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (CSE:SL)(CSE:SL.CN)(CNSX:SL)(OTC PINK:SPRWF) is pleased to announce that it has received final approval from the TSX Venture Exchange (“TSX.V”) to list the Company’s common shares on the TSX.V. The common shares are expected to begin trading on the TSX.V at the opening of markets on June 6, 2017 under the symbol “FIRE”.

Supreme Updates Board of Directors

Supreme Announces Conditional Approval to List on the TSX.V

TORONTO, Ontario, April 10, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (CSE:SL)(CSE:SL.CN) is pleased to announce that it has received conditional approval from the TSX Venture Exchange (“TSX.V”) to list the Company’s common shares on the TSX.V.

Supreme Pharma

Supreme Pharmaceuticals Closes $55 Million Offering

TORONTO, Ontario, Dec. 13, 2016 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (CSE:SL) is pleased to announce the closing of its $50 million bought deal private placement (the “Brokered Offering”) and concurrent $5 million non-brokered private placement (together with the Brokered Offering, the “Offering”) for aggregate gross proceeds of $55 million.

Supreme Pharma

Supreme Closes Private Placement for Aggregate Proceeds of $14,949,755

TORONTO, Ontario, Aug. 30, 2016 /Weed Wire/ — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF) is pleased to announce it has closed the third tranche of its previously announced non-brokered private placement (the “Financing”) for proceeds of $10,610,625 and aggregate proceeds from three tranches of $14,949,755.

Supreme Pharma

Supreme Closes Second Tranche of Private Placement for Aggregate Proceeds of $4.34m and Secures Additional Long Term Supply Agreement

TORONTO, Ontario, July 15, 2016 /Weed Wire/ — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF) is pleased to announce it has closed the second tranche of its previously announced non-brokered private placement (the “Financing”) for proceeds of $723,250 and aggregate proceeds from both tranches of $4,339,130.

Supreme Pharma

Supreme Obtains MMPR License to Cultivate Medical Marijuana

TORONTO, ON, March 11, 2016 /Weed Wire/ — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (OTC PINK:SPRWF)(CSE:SL) is pleased to announce its wholly-owned subsidiary, Advanced Medical Marihuana Canada (“AMMCan”) has been granted a license to cultivate medical marijuana pursuant to the Marihuana for Medical Purposes Regulations (the “MMPR”).


Top